Back
Business
-
Briefly
HYDERABAD: Aurobindo Pharma has received tentative approval to manufacture and market fixed dosed combination, Abacavir Sulfate / Lamivudine tablets 60/30 mg from the U.S. Food and Drug Administration (USFDA). The drug was meant for treatment of HIV infections. — Special Correspondent © Copyright 2000 - 2009 The Hindu |